MainStreet Investment Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.26M | Buy |
93,983
+10,496
| +13% | +$275K | 0.31% | 72 |
|
|
2026
Q1 | $2.34M | Sell |
83,487
-8,173
| -9% | -$218K | 0.35% | 68 |
|
|
2025
Q4 | $2.28M | Sell |
91,660
-17,626
| -16% | -$444K | 0.33% | 67 |
|
|
2025
Q3 | $2.78M | Sell |
109,286
-3,528
| -3% | -$87.1K | 0.37% | 64 |
|
|
2025
Q2 | $2.73M | Sell |
112,814
-3,765
| -3% | -$87.8K | 0.38% | 68 |
|
|
2025
Q1 | $2.95M | Sell |
116,579
-4,163
| -3% | -$109K | 0.43% | 63 |
|
|
2024
Q4 | $3.2M | Sell |
120,742
-16,460
| -12% | -$446K | 0.45% | 62 |
|
|
2024
Q3 | $3.97M | Sell |
137,202
-7,398
| -5% | -$216K | 0.53% | 52 |
|
|
2024
Q2 | $4.05M | Sell |
144,600
-3,555
| -2% | -$97.9K | 0.5% | 56 |
|
|
2024
Q1 | $4.11M | Sell |
148,155
-1,075
| -0.7% | -$29.8K | 0.49% | 54 |
|
|
2023
Q4 | $4.3M | Sell |
149,230
-37,790
| -20% | -$1.14M | 0.49% | 55 |
|
|
2023
Q3 | $6.2M | Sell |
187,020
-5,730
| -3% | -$203K | 0.72% | 39 |
|
|
2023
Q2 | $7.07M | Sell |
192,750
-4,727
| -2% | -$184K | 0.77% | 36 |
|
|
2023
Q1 | $8.06M | Buy |
197,477
+3,099
| +2% | +$134K | 0.87% | 34 |
|
|
2022
Q4 | $9.96M | Sell |
194,378
-8,939
| -4% | -$429K | 1.11% | 23 |
|
|
2022
Q3 | $8.9M | Hold |
203,317
| – | – | 1.08% | 27 |
|
|
2022
Q2 | $10.7M | Sell |
203,317
-3,787
| -2% | -$193K | 1.22% | 22 |
|
|
2022
Q1 | $10.7M | Sell |
207,104
-2,886
| -1% | -$150K | 1% | 27 |
|
|
2021
Q4 | $12.4M | Sell |
209,990
-10
| -0% | -$495 | 1.08% | 24 |
|
|
2021
Q3 | $9.03M | Sell |
210,000
-9,400
| -4% | -$416K | 0.87% | 28 |
|
|
2021
Q2 | $8.59M | Buy |
219,400
+445
| +0.2% | +$17.3K | 0.73% | 37 |
|
|
2021
Q1 | $7.93M | Sell |
218,955
-5,586
| -2% | -$198K | 0.66% | 44 |
|
|
2020
Q4 | $8.27M | Sell |
224,541
-24,899
| -10% | -$913K | 0.66% | 43 |
|
|
2020
Q3 | $8.69M | Buy |
249,440
+2,165
| +0.9% | +$75.9K | 0.68% | 39 |
|
|
2020
Q2 | $7.67M | Sell |
247,275
-33,912
| -12% | -$1.15M | 0.52% | 38 |
|
|
2020
Q1 | $8.71M | Buy |
281,187
+29,087
| +12% | +$991K | 1.07% | 25 |
|
|
2019
Q4 | $9.37M | Buy |
252,100
+13,366
| +6% | +$476K | 1.03% | 26 |
|
|
2019
Q3 | $8.14M | Buy |
238,734
+5,121
| +2% | +$186K | 1.07% | 27 |
|
|
2019
Q2 | $9.6M | Buy |
233,613
+901
| +0.4% | +$35.8K | 1.25% | 22 |
|
|
2019
Q1 | $9.38M | Buy |
232,712
+8,602
| +4% | +$344K | 1.33% | 21 |
|
|
2018
Q4 | $9.28M | Sell |
224,110
-234
| -0.1% | -$9.71K | 1.43% | 19 |
|
|
2018
Q3 | $9.38M | Sell |
224,344
-8,205
| -4% | -$316K | 1.26% | 20 |
|
|
2018
Q2 | $8.01M | Buy |
232,549
+6,101
| +3% | +$208K | 1.16% | 23 |
|
|
2018
Q1 | $7.63M | Sell |
226,448
-918
| -0.4% | -$31.6K | 1.17% | 24 |
|
|
2017
Q4 | $7.81M | Buy |
+227,366
| New | +$7.75M | 1.2% | 23 |
|
Other funds holding PFE
MainStreet Investment Advisors's PFE Position: Q2 2026 in Review
MainStreet Investment Advisors increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $275K and bringing the position to 93,983 shares worth $2.26M. The position accounts for 0.31% of the portfolio, ranked #72.
MainStreet Investment Advisors first reported a position in PFE in Q4 2017 and has held it in 35 quarters since. The position peaked at $12.4M in Q4 2021. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- MainStreet Investment Advisors held 93,983 shares of Pfizer worth $2.26M as of Q2 2026.
- MainStreet Investment Advisors bought 10,496 Pfizer shares in Q2 2026, an estimated $275K.
- Pfizer made up 0.31% of MainStreet Investment Advisors's portfolio in Q2 2026, its #72 holding.
- MainStreet Investment Advisors first reported a position in Pfizer in Q4 2017 and has held it in 35 quarters since.
- MainStreet Investment Advisors's Pfizer position peaked at $12.4M in Q4 2021.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on MainStreet Investment Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.